Alaunos Therapeutics Inc. (TCRT)
NASDAQ: TCRT
· Real-Time Price · USD
2.27
-0.13 (-5.42%)
At close: Aug 15, 2025, 3:59 PM
2.20
-2.87%
After-hours: Aug 15, 2025, 07:31 PM EDT
Alaunos Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.55 | -1.03 | -1.14 | -2.31 | -4.16 | -0.54 | -0.93 | -3.49 | -4.04 | -3.7 | -9.8 | -6.8 | -3.34 | -4.96 | -4.29 | -6.24 | -8.93 |
PEG Ratio | -0.01 | 0.03 | 0.81 | 0.07 | 0.05 | 0.07 | 0.27 | 0.57 | 0.36 | n/a | 2.58 | 1.04 | 0.30 | 0.10 | -22.7 | -1.26 | 1.56 |
PS Ratio | 1.18K | 764.60 | n/a | 2.61K | 28.02K | 16.99K | n/a | 30.57K | n/a | 13.18K | 127.09 | n/a | n/a | n/a | 981.07 | n/a | n/a |
PB Ratio | 2.22 | 1.48 | 1.89 | 2.76 | 5.84 | 2.69 | 2.28 | 5.65 | 5.12 | 3.76 | 11.52 | 6.64 | 2.85 | 4.03 | 5.68 | 6.41 | 7.29 |
P/FCF Ratio | -3.05 | -5.17 | 0.18 | -6.2 | -14.62 | -2.3 | -4.96 | -17.14 | -15.99 | -20.01 | -60.07 | -32.34 | -17.98 | -15.11 | -39.25 | -24.27 | -48.05 |
P/OCF Ratio | -3.05 | -5.17 | 0.19 | -6.2 | -14.62 | -2.3 | -4.96 | -17.47 | -16.1 | -20.34 | -60.21 | -32.56 | -18.05 | -15.47 | -40.77 | -26.39 | -50.3 |
OCF/S Ratio | -386 | -148 | n/a | -420.25 | -1.92K | -7.38K | n/a | -1.75K | n/a | -648.18 | -2.11 | n/a | n/a | n/a | -24.06 | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 0.08 | 0.07 | 0.46 | 0.51 | 0.80 | 0.69 | 0.60 | 0.51 | 0.43 | 0.06 | 0.04 |
Quick Ratio | 1.00 | 3.98 | 4.30 | 5.16 | 4.87 | 4.22 | 2.75 | 3.72 | 2.24 | 1.65 | 1.69 | 2.33 | 3.29 | 4.91 | 3.43 | 6.58 | 5.94 |
Current Ratio | 1.00 | 3.98 | 4.30 | 5.16 | 4.87 | 4.22 | 2.75 | 3.72 | 2.24 | 2.23 | 1.69 | 2.29 | 3.29 | 4.91 | 3.43 | 6.58 | 5.94 |
Asset Turnover | 0.00 | 0.00 | n/a | 0.00 | 0.00 | 0.00 | n/a | 0.00 | n/a | 0.00 | 0.04 | n/a | n/a | n/a | 0.00 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.47 | -11.34 | -9.6 | -9.83 | -12.48 | -13.3 | -14.87 | -51.02 | -730.29 | n/a |
Return on Equity | -1.01 | -0.36 | -0.41 | -0.3 | -0.35 | -1.24 | -0.61 | -0.41 | -0.32 | -0.25 | -0.29 | -0.24 | -0.21 | -0.2 | -0.33 | -0.26 | -0.2 |
Return on Assets | -0.51 | -0.27 | -0.32 | -0.24 | -0.28 | -0.95 | -0.44 | -0.31 | -0.19 | -0.15 | -0.14 | -0.13 | -0.12 | -0.12 | -0.2 | -0.21 | -0.17 |
Return on Invested Capital | -1.03 | -0.37 | -0.42 | -0.31 | -0.36 | -0.48 | -0.57 | -0.34 | -0.21 | -0.16 | -0.15 | -0.13 | -0.12 | -0.13 | -0.23 | -0.24 | -0.19 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | n/a | 0.75 | -1 | -240 | n/a | -382.25 | n/a | -72.18 | 0.76 | n/a | n/a | n/a | 1.00 | n/a | n/a |
Net Profit Margin | -536.5 | -185.5 | n/a | -282.25 | -1.68K | -7.84K | n/a | -2.19K | n/a | -890.64 | -3.24 | n/a | n/a | n/a | -57.12 | n/a | n/a |
Pretax Profit Margin | -536.5 | -185.5 | n/a | -282.25 | -1.68K | -7.84K | n/a | -2.19K | n/a | -832.64 | -3.04 | n/a | n/a | n/a | -57.12 | n/a | n/a |
Operating Profit Margin | -546 | -188.75 | n/a | -291.5 | -1.74K | -3.36K | n/a | -2K | n/a | -774.64 | -2.84 | n/a | n/a | n/a | -56.02 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -536.5 | -185.5 | n/a | -282 | -1.68K | -7.6K | n/a | -1.75K | n/a | -678.73 | -2.51 | n/a | n/a | n/a | -54.31 | n/a | n/a |